Loading…
Clearmind Medicine Inc. is projected to rise to $2.22 by 2027, a +36% move from its current price of $1.63. CMND is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.54 | $1.63 | $1.72 | 0.00% |
| Aug 6 | $1.51 | $1.63 | $1.76 | 0.00% |
| Aug 7 | $1.48 | $1.63 | $1.79 | 0.00% |
| Aug 8 | $1.46 | $1.63 | $1.82 | 0.00% |
| Aug 9 | $1.44 | $1.63 | $1.84 | 0.00% |
| Aug 10 | $1.42 | $1.63 | $1.87 | 0.00% |
| Aug 11 | $1.41 | $1.63 | $1.89 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.41 | $1.63 | $1.89 | -0.01% |
| Week 2 | $1.33 | $1.63 | $2.00 | -0.01% |
| Week 3 | $1.27 | $1.63 | $2.10 | -0.02% |
| Week 4 | $1.22 | $1.63 | $2.18 | -0.02% |
| Week 5 | $1.18 | $1.63 | $2.26 | -0.03% |
| Week 6 | $1.14 | $1.63 | $2.33 | -0.03% |
| Week 7 | $1.11 | $1.63 | $2.40 | -0.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Clearmind Medicine Inc. is a clinical stage pharmaceutical company that develops novel psychedelic medicines to treat under-served health problems. It focuses on developing treatments for conditions such as alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
The company develops the MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has strategic collaborations with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc.
and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
CMND is a publicly traded healthcare stock focused on psychedelic medicines. It currently trades at $1.62 and has a market capitalization of $2.41M, with a market rank of 5132. The near-term picture shows a stable to cautious sentiment, while the longer-term outlook points to a bullish trajectory as price forecasts rise in successive years.
A major floor 71.6% below — a decisive break under it would weaken the trend.
The nearest floor, 10.4% below — buyers have tended to step in here.
The nearest ceiling, 88.3% above — a clean break opens room to run.
A major ceiling 777.3% above — clearing it would confirm fresh momentum.
Key CMND support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CMND market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.57 | Buy | $1.61 | Buy |
| MA 10 | $1.63 | Sell | $1.67 | Sell |
| MA 20 | $1.83 | Sell | $1.88 | Sell |
| MA 50 | $2.47 | Sell | $3.32 | Sell |
| MA 100 | $5.21 | Sell | $16.67 | Sell |
| MA 200 | $52.85 | Sell | $94.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.50 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -45.68 | Neutral |
| Williams %R (14) | -56.60 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -7.14 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 43.40 | Neutral |
| TRIX (15) | -2.14 | Sell |
| Awesome (5,34) | -0.65 | Sell |
| Ultimate (7,14,28) | 43.91 | Neutral |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 1.54 | Buy |
| ADX (14) | 36.15 | Sell |
| ATR (14) | 0.11 | Info |
The 30-day technical picture is neutral. RSI14 is 30, and the price is trading relative to the SMA50 of $2.48 and the SMA200 of $54.75. The price sits above a near-term support of $1.46 and below a key resistance at $3.14.
The 30-day range has traded between $1.12 and $2.34, and annualized volatility is 100%. These factors suggest muted near-term momentum with potential for moves if price tests the defined support or resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.46 | $1.63 | $2.24 | 0% | Neutral | |
| $1.62 | $2.22 | $3.29 | +36% | Bullish | |
| $1.52 | $2.22 | $3.52 | +36% | Bullish | |
| $1.61 | $2.47 | $4.11 | +52% | Bullish | |
| $1.49 | $2.41 | $4.17 | +48% | Bullish | |
| $1.12 | $1.88 | $3.38 | +16% | Neutral | |
| $1.17 | $2.05 | $3.80 | +26% | Bullish | |
| $1.29 | $2.36 | $4.49 | +45% | Bullish | |
| $1.55 | $2.95 | $5.74 | +81% | Bullish | |
| $1.68 | $3.32 | $6.63 | +104% | Bullish | |
| $1.77 | $3.94 | $8.64 | +142% | Bullish | |
| $2.22 | $4.92 | $11.33 | +202% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.46 | $1.63 | $2.02 | +0.00% |
| September 2026 | $1.41 | $1.71 | $2.17 | +4.98% |
| October 2026 | $1.32 | $1.63 | $2.11 | -4.81% |
| November 2026 | $1.25 | $1.56 | $2.05 | -4.18% |
| December 2026 | $1.33 | $1.68 | $2.24 | +7.72% |
Click any year to see its month-by-month CMND forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CMND is projected to trade between $1.46 and $2.24, averaging $1.63 — a potential gain of 0% from today's $1.63. A consolidation phase looks the most probable path here.
Clearmind Medicine Inc.'s 2027 outlook centres on $2.22, within a $1.62 to $3.29 range. That is up +36% on the projected 2026 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2028, CMND could reach as high as $3.52, with a base case around $2.22 and support toward $1.52 — roughly +36% from $1.63. Buyers look set to stay in control over this stretch.
Expect CMND to range from $1.61 to $4.11 through 2029. The $2.47 average target implies a +52% move from current prices. That is up +11% on the projected 2028 average. Momentum favours further upside here.
The CMND price prediction for 2030 points to an average of $2.41 (low $1.49, high $4.17) — a potential gain of +48% on today's $1.63. Buyers look set to stay in control over this stretch.
In 2031, CMND is projected to trade between $1.12 and $3.38, averaging $1.88 — a potential gain of +16% from today's $1.63. That is -22% versus the projected 2030 average. Price action looks broadly range-bound.
Clearmind Medicine Inc.'s 2032 outlook centres on $2.05, within a $1.17 to $3.80 range. That is up +9% on the projected 2031 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CMND could reach as high as $4.49, with a base case around $2.36 and support toward $1.29 — roughly +45% from $1.63. Momentum favours further upside here.
Expect CMND to range from $1.55 to $5.74 through 2034. The $2.95 average target implies a +81% move from current prices. That is up +25% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CMND price prediction for 2035 points to an average of $3.32 (low $1.68, high $6.63) — a potential gain of +104% on today's $1.63. Momentum favours further upside here.
In 2040, CMND is projected to trade between $1.77 and $8.64, averaging $3.94 — a potential gain of +142% from today's $1.63. That is up +19% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Clearmind Medicine Inc.'s 2050 outlook centres on $4.92, within a $2.22 to $11.33 range. That is up +25% on the projected 2040 average. That marks a +202% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CMND today (≈ 613.496933 CMND) could be worth
$3,021.17
+$2,021.17 (+202%) by 2050 · US Dollar
Based on the average projected CMND price of $4.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CMNDwould be worth at today's price.
$1,000 invested in CMND on Jul 31, 2025 (≈ 2.5 CMND) would be worth
$4.07
-$995.93 (-99.6%) today · 0.00× · US Dollar
Based on a CMND entry price of $400 vs. today's $1.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.61 | $1,012.42 | +1.2% |
| 1 month ago | $2.3 | $708.7 | -29.1% |
| 3 months ago | $6.58 | $247.72 | -75.2% |
| 6 months ago | $22.3 | $73.09 | -92.7% |
| 1 year ago | $400 | $4.07 | -99.6% |
| All time (3.7y) ago | $70,800 | $0.02 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CMND forecast.
Our base-case forecast reaches $3.30 around 2035.
Implied market cap at $3.30: $4.9M
The multi-year forecast shows a bullish tilt starting in 2027 and extending through 2050. In 2026 the avg price is $1.62 with ROI 0 and sentiment NEUTRAL. The forward years display a positive trajectory: 2027 avg $2.20 (ROI 36%), 2028 avg $2.22 (ROI 36.9%), 2029 avg $2.48 (ROI 53.3%), 2030 avg $2.39 (ROI 47.7%), 2031 avg $1.86 (ROI 15%), 2032 avg $2.05 (ROI 26.8%), 2033 avg $2.35 (ROI 45.2%), 2034 avg $2.94 (ROI 81.7%), 2035 avg $3.33 (ROI 105.8%), 2040 avg $3.93 (ROI 142.7%), and 2050 avg $4.93 (ROI 204.6%), with sentiment remaining BULLISH in most years.
These are estimates and not guarantees, but they illustrate a path of increasing price potential over time with higher ceilings in the outer years.
Tap a question to reveal the answer.
In 2030 the forecast shows an avg price of $2.39, a min of $1.48, and a max of $4.14, with an ROI of 47.7% and a bullish sentiment.
The forecast turns bullish after 2026, with 2027 avg $2.20 (ROI 36%), 2028 avg $2.22 (ROI 36.9%), 2029 avg $2.48 (ROI 53.3%), and 2030 avg $2.39 (ROI 47.7%), suggesting rising potential alongside higher ROI in several years.
Yes. The max forecast values show $5.74 in 2034, $6.65 in 2035, $8.62 in 2040, and $11.35 in 2050, indicating moments where the price could exceed $5 in the forecast horizon.
The 30-day range is $1.12 to $2.34.
The current price is $1.62 and the market cap is $2.41M, with a market rank of 5132.
Clearmind Medicine Inc. Community Discussion
0Share your Clearmind Medicine Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.